Gene · 3663
Papers4,211
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
901 to 920 of 4,211
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bioinformatic analysis of the role of solute carrier-glutamine transporters in breast cancer. | Ann Transl Med | 2022 | 35965834 | PubTator, text mining | PubMed |
| Characteristics and genetic analysis of patients suspected with early-onset systemic lupus erythematosus. | Pediatr Rheumatol Online J | 2022 | 35964089 | PubTator, text mining | PubMed |
| MAP3K7 is an innate immune regulatory gene with increased expression in human and murine kidney intercalated cells following uropathogenic Escherichia coli exposure. | J Cell Biochem | 2022 | 35959632 | PubTator, text mining | PubMed |
| Detection of neutrophil extracellular traps in patient plasma: method development and validation in systemic lupus erythematosus and healthy donors that carry IRF5 genetic risk. | Front Immunol | 2022 | 35958624 | PubTator, text mining | PubMed |
| Synovial Macrophages: Past Life, Current Situation, and Application in Inflammatory Arthritis. | Front Immunol | 2022 | 35958604 | PubTator, text mining | PubMed |
| Identification and validation of an immune signature associated with EMT and metabolic reprogramming for predicting prognosis and drug response in bladder cancer. | Front Immunol | 2022 | 35958586 | PubTator, text mining | PubMed |
| Kidney transplantation in systemic sclerosis: Advances in graft, disease, and patient outcome. | Front Immunol | 2022 | 35958558 | PubTator, text mining | PubMed |
| Associations of Dynapenic Obesity and Sarcopenic Obesity with the Risk of Complications in COVID-19. | Int J Mol Sci | 2022 | 35955411 | PubTator, text mining | PubMed |
The Association between a Decrease in On-Treatment Neutrophil-to-Eosinophil Ratio (NER) at Week 6 after Ipilimumab Plus Nivolumab Initiation and Improved Clinical Outcomes in Metastatic Renal Cell Carcinoma. | Cancers (Basel) | 2022 | 35954493 | PubTator, text mining | PubMed |
| Immunology Meets Bioengineering: Improving the Effectiveness of Glioblastoma Immunotherapy. | Cancers (Basel) | 2022 | 35954362 | PubTator, text mining | PubMed |
| Germline Variants Associated with Nasopharyngeal Carcinoma Predisposition Identified through Whole-Exome Sequencing. | Cancers (Basel) | 2022 | 35954343 | PubTator, text mining | PubMed |
| A CRISPRi/a platform in human iPSC-derived microglia uncovers regulators of disease states. | Nat Neurosci | 2022 | 35953545 | PubTator, text mining | PubMed |
| Autoimmune liver diseases in systemic rheumatic diseases. | World J Gastroenterol | 2022 | 35949355 | PubTator, text mining | PubMed |
| Discoidin domain receptor 1 is a potential target correlated with tumor invasion and immune infiltration in gastric cancer. | Front Immunol | 2022 | 35935941 | PubTator, text mining | PubMed |
| Transcriptional and reverse transcriptional regulation of host genes by human endogenous retroviruses in cancers. | Front Microbiol | 2022 | 35928153 | PubTator, text mining | PubMed |
| The Impact of Inflammation-Induced Tumor Plasticity during Myeloid Transformation. | Cancer Discov | 2022 | 35924979 | PubTator, text mining | PubMed |
| An analysis of the significance of the Tre2/Bub2/CDC 16 (TBC) domain protein family 8 in colorectal cancer. | Sci Rep | 2022 | 35918393 | PubTator, text mining | PubMed |
| High expression of RRM2 mediated by non-coding RNAs correlates with poor prognosis and tumor immune infiltration of hepatocellular carcinoma. | Front Med (Lausanne) | 2022 | 35911380 | PubTator, text mining | PubMed |
| Mycobiota and C-Type Lectin Receptors in Cancers: Know thy Neighbors. | Front Microbiol | 2022 | 35910636 | PubTator, text mining | PubMed |
| Transcriptome Analysis Reveals the Mechanism of Natural Ovarian Ageing. | Front Endocrinol (Lausanne) | 2022 | 35909541 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3663/papers?page=46